VRC07-523LS Clinical Trials
5 recruitingDrug
Phase 14Phase 23
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)1,120 enrolled46 locationsNCT02140255
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Phase 1
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled17 locationsNCT06517693
Recruiting
Phase 1
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
HIV InfectionsARTAcute HIV Infection+1 more
Henry M. Jackson Foundation for the Advancement of Military Medicine48 enrolled1 locationNCT06484335
Recruiting
Phase 1Phase 2
The Tatelo Plus Study
HIV InfectionsHIV
National Institute of Allergy and Infectious Diseases (NIAID)41 enrolled2 locationsNCT06508749